Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

February 22, 2019

Study Completion Date

February 22, 2019

Conditions
Colitis, UlcerativeCrohn's Disease
Interventions
DRUG

Vedolizumab

Vedolizumab IV infusion

Trial Locations (7)

27599

University of North Carolina at Chapel Hill, Chapel Hill

60637

Feinberg School of Medicine Northwestern University, Chicago

61801

Carle Foundation Hospital, Urbana

77030

Baylor College of Medicine, Houston

80045

University of Colorado, Aurora

07960

Atlantic Health System, Morristown

37212-1150

Vanderbilt University Medical Center, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY